Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 21,996 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Stage I Prostate Cancer AJCC v7, Stage II Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Cancer AJCC v7
Interventions: Biospecimen Collection, Electronic Health Record Review, Quality-of-Life Assessment, Questionnaire Administration; Procedure · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Duarte, California

Conditions: Adolescent Behavior
Interventions: Family Media Check-In (FMC); Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 11 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Mesothelioma
Interventions: Magnesium sulfate, Normal Saline; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Musculoskeletal Injury, Musculoskeletal Diseases, Peripheral Nervous System Diseases
Interventions: Tall Soft, Tall Firm, Short Soft, Short Firm; Device
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Central Nervous System Disease, Multiple Sclerosis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 1 Month to 99 Years
Enrollment: 2,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Kidney Transplantation, Mycophenolate Mofetil
Interventions: Mycophenolate Mofetil (MMF) Maintenance Group, Mycophenolate Mofetil (MMF) Withdrawal Group; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 55 Years and older
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2031
U.S. locations: 3
States / cities: Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Methamphetamine-dependence
Interventions: Semaglutide, Placebo; Drug
Lead sponsor: San Francisco Department of Public Health; Government
Eligibility: 18 Years to 65 Years
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Withdrawal Symptoms, Opioid Use Disorder, Opioid Use
Interventions: Transcutaneous Cervical Vagal Nerve Stimulation, Sham Stimulation, [F-18]Fallypride; Device · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Atlanta, Georgia

Conditions: Premature Birth, Breastfeeding, Exclusive, Feeding; Difficult, Newborn
Interventions: taVNS soterix device; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 35 Weeks and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Irreversible Pulpitis, Apical Periodontitis, Pulpal Necrosis
Interventions: Not listed
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 89 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Ureteral Stone
Interventions: Reverse Trendelenburg Position, T-Tilt Position; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Weight Loss, Postpartum Weight Retention
Interventions: Counseling with goal of modifying eating behaviors; Behavioral
Lead sponsor: Tripler Army Medical Center; Federal
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Honolulu, Hawaii • Schofield Barracks, Hawaii

Conditions: Sarcoidosis
Interventions: Sarcoidosis diagnosis; Other
Lead sponsor: Foundation for Sarcoidosis Research; Other
Eligibility: 7 Years and older
Enrollment: 6,833 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2033
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Adverse Childhood Experiences, Endothelial Dysfunction
Interventions: Nicotinamide Riboside, Placebo; Dietary Supplement
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 30 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Iowa City, Iowa • Madison, Wisconsin

Conditions: Normal Aging
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2050
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions: Sipuleucel-T Injection; Drug
Lead sponsor: Dendreon; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2032
U.S. locations: 31
States / cities: Tuscon, Arizona • Duarte, California • Fresno, California + 28 more

Conditions: Myopia, Astigmatism
Interventions: Ray-Tracing Guided LASIK, Keratorefractive Lenticule Extraction (KLEx), WaveFront Optimized LASIK, Topography Guided LASIK; Device
Lead sponsor: Hoopes Vision; Other
Eligibility: 22 Years to 50 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Draper, Utah

Conditions: Muscle Damage, Muscle
Interventions: Placebo control capsules, PeptiStrong® supplement capsules with same appearance as placebo capsules, PeptiStrong® supplement capsules following muscle damaging exercise on Day 14; Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Bradenton, Florida

Conditions: Cancer, Breast Cancer
Interventions: Resistance Training with Cardio, Resistance Training with Conditioning; Behavioral
Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute); Other
Eligibility: 20 Years to 89 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Type I Diabetes
Interventions: OPT101, OPT101 Placebo to Match (PTM); Drug · Other
Lead sponsor: Op-T LLC; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Birmingham, Alabama • Walnut Creek, California • Aurora, Colorado + 2 more

Conditions: Arthritis, Rheumatoid
Interventions: BMS-986528; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 11
States / cities: La Jolla, California • Loma Linda, California • Palo Alto, California + 7 more

Conditions: Healthy
Interventions: Monosaccharide Powder, Placebo Comparator; Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 45 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Muscle-Invasive Bladder Carcinoma, Metastatic Urothelial Carcinoma
Interventions: SEphB4-HSA, Pembrolizumab, Gemcitabine, Cisplatin, Enfortumab vedotin; Drug
Lead sponsor: Vasgene Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Spinal Cord Injury, Paraplegia and Tetraplegia
Interventions: Hands-free exoskeleton; Device
Lead sponsor: Wandercraft; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer

Using Shared Decision Making to Improve Family Media Use Planning

MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI

The Effects of AFO Heel Height and Stiffness on Gait

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

Glutide for Ending Methamphetamine

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge

Bite Force Measurements

Patient Positioning for Treatment of Proximal Ureteral Stones

Weight Loss and Physical Fitness Following Pregnancy in Active Duty Women

Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)

ACEs, SIRT1, and Premature Vascular Aging in Humans

Collection of Bone Marrow Aspirate From Normal Volunteers

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism

The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

The Effects of Dietary Supplementation on Serum Protein Glycosylation

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Self-balancing Personal Exoskeleton for SCI (WINY)